Investor Presentaiton

2 INVESTOR 20 DAY 23 Smart Liquid Biopsy analyzes 1,000s of regions in cfDNA with leading sensitivity at low-cost 1 High performance in detecting early- stage cancer Positive unit economics to scale shield™ Broad reimbursement & access Patient preference 3 GUARDANT™ 4 103

View entire presentation